Therapeutic drug monitoring;Therapeutisches Drug-Monitoring (TDM)

Krankenhauspharmazie

Volumn 30, Issue 5, 2009, Pages 222-224

  Frey, Otto R ^a  

^a Apotheke der Kliniken Landkreis Heidenheim gCmbH   (Germany)

Author keywords

Dose adjustment; Interdisciplinary cooperation; Therapeutic drug monitoring; Therapy adjustment

Indexed keywords

AMIKACIN; AMISULPRIDE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CLONAZEPAM; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN; CYTOSTATIC AGENT; DIAZEPAM; DIGOXIN; ETIRACETAM; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; LAMOTRIGINE; MEROPENEM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PIPERACILLIN; PRIMIDONE; RAPAMYCIN; SULTIAME; TACROLIMUS; THEOPHYLLINE; TOPIRAMATE; UNINDEXED DRUG; VANCOMYCIN;

BODY HEIGHT; BODY WEIGHT; CREATININE CLEARANCE; DRUG INDICATION; DRUG MONITORING; HUMAN; PATIENT MONITORING; SHORT SURVEY;

EID: 70049118573     PISSN: 01737597     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC. Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies. Epilepsia 2008;49:1239-76.
2. Winter ME. Basic Clinical Pharmacokinetics. 4. Auflage. Philadelphia: Lippincott Raven, 2003.
3. Dhillon S, Kostrzewski A (Eds.). Clinical Pharmacokinetics. 1. Auflage. London: Pharmaceutical Press, 2006.
4. Murphy JE. Clinical Pharmacokinetics. 4. Auflage. Bethesda: American Society of Health System Pharmacy, 2007.
5. Murphy R, Chionglo M, Dupuis LL. Impact of a pharmacist-initiated therapeutic drug monitoring consult service for children treated with gentamicin. Can J Hops Pharm 2007:60:162-8.
6. Brandt C, Baumann P, Eckermann G, Hiemke C, et al. Therapeutisches Drug-Monitoring in Epileptologie und Psychiatrie. Nervenarzt 2008;79:167-74.